RIFAMPIN
Generic: RIFAMPIN
RIFAMPIN is FDA application ANDA091181, sponsored by FRESENIUS KABI USA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
CGMP Deviations:OOS result was observed in 1-Methyl-4-Nitroso Piperazine (MNP) impurity.
Failed Impurities/Degradation Specifications; out-of-specification for color, impurity, and degradat
Subpotent Drug and Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specification.
Failed Impurities/Degradations Specifications
Subpotent Drug and Failed Impurities/Degradation Specifications
Failed Impurities/Degradation Specifications: High out of specification results obtained for related
Failed Impurities/Degradation Specifications: Failure observed in related substance testing during l
Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results